TetraVax-DV-TV003 (Butantan Institute)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTetraVax-DV-TV003 (Butantan Institute)
Drug Alias NameDengue 1,2,3,4 (attenuated) vaccineTetraVax-DV-TV003
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto Butantan
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Butantan
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A